Avacta Life Sciences Ltd

This is the first human study of an experimental cancer drug called AVA6103. It's being tested in adults with advanced solid tumors that have spread or can't be surgically removed, including pancreatic, lung, gastric, and cervical cancers. The trial aims to find the safest dose a…

This is a first-in-human study testing a new cancer drug called AVA6000 in patients with advanced solid tumors that have spread or cannot be removed by surgery. The drug is a modified version of a common chemotherapy (doxorubicin) designed to be activated only inside tumors, pote…